Program
Break
Ceremony/Networking
Debate Session
E-Poster Discussions
Free Communications
Scientific Session
Sponsored Sessions
Break
Ceremony/Networking
Debate Session
E-Poster Discussions
Free Communications
Scientific Session
Sponsored Sessions
Time | Hall Perla | Hall Mosaici 2 | Station 01 | Station 02 | Station 03 | Station 04 | Exhibition |
---|---|---|---|---|---|---|---|
12:55-13:00 |
Brief Welcome
|
||||||
13:00-14:00 |
Debate 01: What Should We Use As the First-Line Treatment for RA?
|
Debate 02: Are the New Classification Criteria a Step Forward in the Management of Antiphospholipid Syndrome?
|
|||||
14:10-15:10 |
Debate 03: LN Treatment: Early Combination vs. Standard Treatment
|
Debate 04: The Use of Medical Cannabis in Rheumatic Pain Management: Valid Option or Unproven Treatment?
|
|||||
15:10-15:40 |
E-Poster Discussion 01: Systemic Sclerosis
|
E-Poster Discussion 02: Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Sjögren Syndrome
|
E-Poster Discussion 03: Interstitial Lung Disease and COVID Vaccine
|
E-Poster Discussion 04: Systemic Lupus Erythematosus
|
Coffee Break, Exhibition and E-Poster Discussions
|
||
15:40-16:40 |
Sponsored Session (not included in the main event CME/CPD credit)
|
||||||
16:50-17:50 |
Scientific Session 01: Rheumatoid Arthritis and Pain
|
Free Communications 01: SLE – From the Bedside to the Bench
|
|||||
18:00-19:00 |
Opening Ceremony
|
||||||
19:00-20:00 |
Welcome Reception
|
Time | Hall Perla | Hall Mosaici 2 | Station 01 | Station 02 | Exhibition | Offsite (Hilton Molino Stucky Venice) |
---|---|---|---|---|---|---|
08:30-09:00 |
Scientific Session 02: The New Therapeutic Options in GPA and MPA
|
|||||
09:05-10:05 |
Debate 05: Beyond Physical Examination – How to Approach to RA Management: Joint Ultrasound or Synovial Biopsy?
|
Debate 06: Mepolizumab in EGPA: Does One Size Fit All?
|
||||
10:05-10:45 |
Coffee Break and Exhibition
|
|||||
10:10-10:40 |
Sponsored Session (not included in the main event CME/CPD credit)
|
|||||
10:45-11:45 |
Debate 07: TNFi or IL17i for the Slowing the Radiographic Progression in Spondyloarthritis?
|
Debate 08: Gut Microbiome in Rheumatic Diseases: Revolutionary or Fake News?
|
||||
11:50-12:50 |
Debate 09: CAR-T Cells in Rheumatic Diseases: Game-Changer or Just a Buzz?
|
Debate 10: Is Seronegative Sjogren Syndrome a Distinct Clinical Entity? & Should Hydroxychloroquine Be Used in Patients With Sjogren Syndrome?
|
||||
12:50-13:50 |
Lunch Break and Exhibition
|
|||||
13:00-14:00 |
Sponsored Session (not included in the main event CME/CPD credit)
|
|||||
14:10-15:10 |
Free Communications 02: SLE – Clinical Aspects
|
Free Communications 03: Open Issues and Novelties in ARD
|
||||
15:15-16:15 |
Debate 11: Early Biologic Treatment in Systemic Lupus: Necessary or Overemphasized?
|
Debate 12: Is Hematopoietic Stem Cell Transplantation (Really) a Valid Option for Patients With Systemic Sclerosis?
|
||||
16:15-16:45 |
E-Poster Discussion 05: SLE, MCTD, Machine Learning
|
E-Poster Discussion 06: Autoinflammatory Diseases, IgG4-Related Disease, Vasculitis
|
Coffee Break, Exhibition and E-Poster Discussions
|
|||
16:45-17:45 |
Debate 13: Can We Give Targeted Therapies in Patients With Cancer?
|
Debate 14: Are IPAF and UCTD Two Clinical Variants of the Same Systemic Autoimmune Disorder?
|
||||
17:50-18:50 |
Debate 15: Do JAK Inhibitors Aggravate Comorbidities Such As Cardiovascular Disease and Cancer?
|
Free Communications 04: APS and Pregnancy in Rheumatological Diseases
|
||||
20:30-23:59 |
Networking Event
|
Time | Hall Perla | Hall Mosaici 2 | Station 01 | Station 02 | Station 03 | Station 04 | Exhibition |
---|---|---|---|---|---|---|---|
09:00-10:00 |
Debate 16: Should We Treat preRA/at Risk RA Individuals or Not?
|
Debate 17: Is It Common To Achieve the T2T Goals in SLE Patients?
|
|||||
10:00-10:30 |
E-Poster Discussion 07: Rheumatoid Arthritis
|
E-Poster Discussion 08: Spondyloarthritis, Hashimoto Thyroiditis
|
E-Poster Discussion 09: Antiphospholipid Antibody Syndrome, Pregnancy in Rheumatic Diseases
|
E-Poster Discussion 10: Fibromyalgia, Hypermobility Syndrome
|
Coffee Break, Exhibition and E-Poster Discussions
|
||
10:30-11:30 |
Scientific Session 03: Prevention in Autoimmunity
|
Free Communications 05: Vasculitis, SLE and Sjögren's Syndrome
|
|||||
11:35-12:35 |
Debate 18: Axial Psoriatic Arthritis and axSpA: To Lump or to Split
|
Debate 19: Should Immunosuppressive Drugs Be Used in All Patients With the Limited Cutaneous Form of SSc?
|
|||||
12:35-13:35 |
Lunch Break and Exhibition
|
||||||
12:45-13:45 |
Sponsored Session (not included in the main event CME/CPD credit)
|
||||||
13:55-14:55 |
Scientific Session 04: Chat GPT vs. Hippocrates in Autoimmunity
|
Free Communications 06: Pearls in Autoimmunity
|
|||||
15:00-16:00 |
Debate 20: Is It Safe to Use Low-Dose Glucocorticoids in GCA?
|
Debate 21: Transition From Psoriasis to Psoriatic Arthritis: Are We Getting Closer?
|
|||||
16:00-16:30 |
Award Ceremony
|